Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

SNYR vs COR: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

COR Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 7–3 Matrix Metrics)

COR Overall Winner 6-Pillar Tally: SNYR 2 – 4 COR Matrix Metrics: SNYR 3 – 7 COR

As of Nov 20, 2026, Cencora, Inc. (COR) is the stronger overall head-to-head candidate over Synergy CHC Corp. (SNYR) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). SNYR carries a Unified Composite Score of 48.9/100 (HOLD) at $0.09 (0.6x Forward P/E, -10.3% operating margin), whereas COR carries 46.8/100 (HOLD) at $339.09 (17.2x Forward P/E, 1.4% operating margin).

  • Composite vs. Pillar Nuance: While SNYR currently prints a higher short-term Unified Composite Score (48.9/100 HOLD vs. COR 46.8/100 HOLD), COR captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (1.4% vs. -10.3% operating margin) and revenue trajectory (+5.5% vs. -32.8% YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About SNYR vs COR
SNYR NASDAQ
Synergy CHC Corp. Common Stock
Medicinal Chemicals & Botanical Products
$0.09
-67.02% 1D
Market Cap $4.1M
TTM Revenue $28M
Forward P/E 0.6x
Beta / 30D Vol -0.86β · 868% Vol
Unified Composite Score
48.9 / 100 HOLD
Tech 55.0 Fund 39.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 46
RSI-14: 46.3 · SMA20: $0.11 · SMA50: $0.14
COR NYSE Head-to-Head Winner
Cencora, Inc.
Wholesale-Drugs, Proprietaries & Druggists' Sundries
$339.09
-0.63% 1D
Market Cap $65.1B
TTM Revenue $337.4B
Forward P/E 17.2x
Beta / 30D Vol 0.03β · 31% Vol
Unified Composite Score
46.8 / 100 HOLD
Tech 41.0 Fund 44.0 Flow 55.0 Mom 36.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 49
RSI-14: 49.1 · SMA20: $341.78 · SMA50: $329.46

6-Pillar Scorecard Institutional Category Breakdown (SNYR 2 – 4 COR)

Columns: Metric · SNYR · COR
1. Valuation Multiples SNYR
Forward P/E 0.6x 17.2x
Trailing P/E 0.6x 19.4x
PEG Ratio N/M 0.77x
EV / Revenue 0.1x 0.2x
2. Growth & Scale COR
Revenue Growth (YoY) -32.8% +5.5%
Earnings Growth (YoY) -90.6% +11.9%
TTM Revenue (USD) $28M $337.4B
Market Cap $4.1M $65.1B
3. Profitability & Quality COR
Gross Margin 65.4% 4.1%
Operating Margin -10.3% 1.4%
Net Profit Margin -57.0% 1.0%
Return on Equity (ROE) -361.1% 129.0%
4. Balance Sheet & Cash Flow COR
Cash Generation (TTM) -$3.8M $5.72B EBITDA
Cash Flow Margin -13.7% 1.7% EBITDA Mgn
Net Cash / Leverage -361.1% ROE $19.29 Book/Sh · 129.0% ROE
Dividend Yield None (0.00%) 0.69%
5. Options & Positioning COR
Options Structure Phase UNCLASSIFIED CONSOLIDATION
Current IV / %ile N/A (N/A) 56.9% (7th %ile)
Put/Call OI Skew N/A 1.30x (Put-Skewed)
OBV Trend / Tech Phase NEUTRAL · Neutral DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat SNYR
OpEx & R&D Intensity 75.7% of Rev ($21M) 2.7% of Rev ($9.11B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning High-Margin Pricing Power Moat
Supply-Chain Role Medical Distribution Operator Medical Distribution Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: SNYR (3) vs COR (7)
Institutional Metric SNYR COR Criterion Row Edge
Market Capitalization
Scale
$4.1M $65.1B Larger Scale COR
Trailing P/E Ratio
Valuation
0.6x 19.4x Lower Multiple SNYR
Forward P/E Ratio
Valuation
0.6x 17.2x Lower Multiple SNYR
Revenue Growth (YoY)
Growth
-32.8% +5.5% Higher Growth COR
Operating Margin (TTM)
Profitability
-10.3% 1.4% Higher Margin COR
Net Profit Margin
Profitability
-57.0% 1.0% Higher Margin COR
Return on Equity (ROE)
Capital Efficiency
-361.1% 129.0% Higher ROE COR
52-Week Range Position
Momentum
1% ($0–$3) 71% ($245–$378) Stronger Trend COR
Beta / 30D Volatility
Risk Regime
-0.86β · 868% Vol 0.03β · 31% Vol Lower Realized Risk COR
Unified Institutional Score
Composite Signal
48.9 / 100 (HOLD) 46.8 / 100 (HOLD) Higher Composite SNYR
Trailing 12M Revenue (USD)
Operating Scale
$28M $337.4B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
65.4% 4.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.1x EV/Rev 0.77x PEG · 0.2x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$3.8M (-361.1% ROE) $5.72B EBITDA ($19.29 Book/Sh · 129.0% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon COR +14.15 pp
SNYR: -16.28% · COR: -2.13%
3M Horizon COR +68.3 pp
SNYR: -56.64% · COR: +11.66%
6M Horizon COR +88.35 pp
SNYR: -93.2% · COR: -4.85%
1Y Horizon COR +81.9 pp
SNYR: -96.13% · COR: -14.23%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period SNYR Revenue COR Revenue SNYR Op. Margin COR Op. Margin Margin Leader
FY2018 $30M $167.9B -14.5% 0.9% COR
FY2019 $30M $179.6B -27.1% 0.6% COR
FY2020 N/A $189.9B N/A -2.7% COR
FY2021 N/A $214.0B N/A 1.1% COR
FY2022 N/A $238.6B N/A 1.0% COR
FY2023 $40M $262.2B 25.3% 0.9% SNYR
FY2024 $30M $294.0B 16.7% 0.7% SNYR
FY2025 $30M $321.3B -27.8% 0.8% COR

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
SNYR UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact SNYR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
COR CONSOLIDATION
72d in phase · OBV DISTRIBUTION
Current IV 56.9%
IV Percentile 7th %ile
Put/Call OI Skew 1.30x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow DISTRIBUTION
Exact COR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $356.94 · IV 27.0%

COR Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($35,694)

Compare $35,694 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 27.0% ATM IV.

5-DAY BULLISH SWING Liq C

Dec 18 $360 / $380 Bull Call Spread

Buy 1x $360C · Sell 1x $380C · 32d

Net Entry $645 Debit
T+5d @ +5% Move +$469 (+73%)
Max Risk / Buffer $645 Capped
5d Edge & Liquidity 1.0x R:R · Liq C
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq C

Dec 18 $340 / $310 Bull Put Spread

Sell 1x $340P · Buy 1x $310P · 32d

Net Entry $286 Credit
Max Credit / Yield +$286 (+10.5% RoM)
Max Risk / Buffer -5.5% Cushion ($2,714 Mgn)
5d Edge & Liquidity 76% PoP · Liq C
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
SNYR Moat Profile Cyclical / Execution-Driven Positioning
Medical Distribution Operator
Competes within the Medical Distribution value chain with $4.1M market capitalization and -10.3% operating margin.
OpEx & R&D Reinvestment 75.7% of Rev ($21M)
90D Engineering Disclosures 0 Published
COR Moat Profile High-Margin Pricing Power Moat
Medical Distribution Operator
Competes within the Medical Distribution value chain with $65.1B market capitalization and 1.4% operating margin.
OpEx & R&D Reinvestment 2.7% of Rev ($9.11B)
90D Engineering Disclosures 0 Published

Investor FAQ SNYR vs COR Key Questions & Quantitative Answers

As of Nov 20, 2026, Cencora, Inc. (COR) is the stronger overall head-to-head candidate over Synergy CHC Corp. (SNYR) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). SNYR carries a Unified Composite Score of 48.9/100 (HOLD) at $0.09 (0.6x Forward P/E, -10.3% operating margin), whereas COR carries 46.8/100 (HOLD) at $339.09 (17.2x Forward P/E, 1.4% operating margin). Composite vs. Pillar Nuance: While SNYR currently prints a higher short-term Unified Composite Score (48.9/100 HOLD vs. COR 46.8/100 HOLD), COR captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (1.4% vs. -10.3% operating margin) and revenue trajectory (+5.5% vs. -32.8% YoY).

COR leads the Growth & Scale pillar: SNYR posts -32.8% YoY revenue growth and -90.6% YoY earnings growth on $28M TTM revenue (65.4% gross margin, -10.3% operating margin), compared with COR at +5.5% YoY revenue growth and +11.9% YoY earnings growth on $337.4B TTM revenue (4.1% gross margin, 1.4% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), SNYR cumulative revenue shifted +0.0% while COR shifted +91.3%. In operating R&D and SG&A reinvestment, SNYR deploys 75.7% of Rev ($21M) (0 90-day corporate R&D disclosures) versus 2.7% of Rev ($9.11B) (0 disclosures) for COR.

SNYR screens cheaper on headline valuation multiples. SNYR trades at 0.6x Forward P/E, 0.6x Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-13.7% FCF margin), whereas COR trades at 17.2x Forward P/E, 19.4x Trailing P/E, 0.77x PEG, and 0.2x EV/Revenue (1.7% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SNYR (-361.1% ROE) versus COR (129.0% ROE) capital efficiency.

In options market volatility and institutional positioning, SNYR carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.86β · 868% Vol realized risk). By comparison, COR carries 56.9% implied volatility (7th %ile, Compressed (<25th %ile)), a 1.30x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.03β · 31% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.